Literature DB >> 27322042

Lubricant Use and Rectal Chlamydial and Gonococcal Infections Among Men Who Engage in Receptive Anal Intercourse.

Courtney Maierhofer1, Cara E Rice, Shu-Hua Wang, Karen S Fields, Melissa Ervin, Abigail Norris Turner.   

Abstract

BACKGROUND: Use of lubricants during anal intercourse is very common among men who have sex with men. However, few studies have evaluated associations between specific lubricants and rectal sexually transmitted infections (STIs).
METHODS: Between July 2012 and October 2013, we conducted a cross-sectional study of men who have sex with men recruited from an urban, public sexual health clinic. In a self-administered survey, participants identified the lubricants used and frequency of lubricant use in the previous three months. Among men reporting any receptive anal intercourse (RAI) in the previous 3 months, we used multivariable binomial regression models to analyze associations between recent use of 9 specific lubricants and prevalent rectal chlamydia, rectal gonorrhea, and either rectal infection.
RESULTS: Twenty-five percent of the 146 participants had rectal chlamydial infection and 21% had rectal gonococcal infection; 37% had either (chlamydial or gonococcal) infection. Three-quarters reported always or almost always using lubricant during recent receptive anal intercourse. After adjustment for age, race, human immunodeficiency virus status, and condom use, Gun Oil (adjusted prevalence ratio [aPR], 1.99; 95% confidence interval [CI], 1.04-3.80) and Slick (aPR, 3.55; 95% CI, 1.38-9.12) were significantly associated with prevalent gonococcal infection. No lubricants were significantly associated with prevalent rectal chlamydia, but in analyses of either rectal infection, precum (aPR, 1.68; 95% CI, 1.06-2.66), Vaseline (aPR, 1.70; 95% CI, 1.10-2.64), and baby oil (aPR, 2.26; 95% CI, 1.43-3.57) were all significantly associated with prevalent rectal infection.
CONCLUSIONS: Several lubricants were significantly associated with increased prevalence of rectal STI. Longitudinal studies are needed to examine any causal relationship between specific lubricants and STI acquisition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27322042     DOI: 10.1097/OLQ.0000000000000463

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  5 in total

1.  Lubricants and rectal douching: associations with rectal gonorrhea, chlamydia, and/or syphilis infection among men who have sex with men.

Authors:  Cheríe S Blair; Marjan Javanbakht; W Scott Comulada; E India Richter; Robert Bolan; Steven Shoptaw; Pamina M Gorbach
Journal:  Int J STD AIDS       Date:  2020-08-04       Impact factor: 1.359

2.  A Web of Complexity: Untangling the Routes of Rectal Chlamydia Acquisition.

Authors:  Christine M Khosropour; Julia C Dombrowski
Journal:  Sex Transm Dis       Date:  2018-08       Impact factor: 2.830

3.  Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol.

Authors:  Andrew Lau; Fabian Kong; Christopher K Fairley; Basil Donovan; Marcus Chen; Catriona Bradshaw; Mark Boyd; Janaki Amin; Peter Timms; Sepehr Tabrizi; David G Regan; David A Lewis; Anna McNulty; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2017-01-06       Impact factor: 3.090

4.  Vaginal cytokine profile and microbiota before and after lubricant use compared with condomless vaginal sex: a preliminary observational study.

Authors:  Susan Tuddenham; Christina A Stennett; Richard A Cone; Jacques Ravel; Andrew N Macintyre; Khalil G Ghanem; Xin He; Rebecca M Brotman
Journal:  BMC Infect Dis       Date:  2021-09-18       Impact factor: 3.090

Review 5.  Lubricants for the promotion of sexual health and well-being: a systematic review.

Authors:  Caitlin E Kennedy; Ping Teresa Yeh; Jingjia Li; Lianne Gonsalves; Manjulaa Narasimhan
Journal:  Sex Reprod Health Matters       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.